Procyrion Revenue and Competitors
Estimated Revenue & Valuation
- Procyrion's estimated annual revenue is currently $10.3M per year.
- Procyrion's estimated revenue per employee is $251,000
Employee Data
- Procyrion has 41 Employees.
Procyrion's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Quality | Reveal Email/Phone |
2 | VP, Product Development | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | SVP, Development and Manufacturing | Reveal Email/Phone |
5 | Sr. Director, Clinical | Reveal Email/Phone |
6 | Founder/Chief Medical Officer | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Associate Director | Reveal Email/Phone |
9 | Director, Field Clinical Engineering | Reveal Email/Phone |
10 | Director, Program Management | Reveal Email/Phone |
Procyrion Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.6M | 74 | 21% | N/A | N/A |
#2 | $37.7M | 150 | -7% | N/A | N/A |
#3 | $1.4M | 11 | -31% | $5.1M | N/A |
#4 | $49.7M | 198 | 14% | N/A | N/A |
#5 | $1.3M | 10 | 0% | $6.3M | N/A |
#6 | $60.7M | 242 | N/A | N/A | N/A |
#7 | $28.1M | 112 | 8% | N/A | N/A |
#8 | $5.5M | 22 | -19% | N/A | N/A |
#9 | $3M | 12 | -20% | N/A | N/A |
#10 | $10.3M | 41 | N/A | N/A | N/A |
What Is Procyrion?
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.
keywords:N/AN/A
Total Funding
41
Number of Employees
$10.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 41 | 5% | N/A |
#2 | $8M | 41 | N/A | N/A |
#3 | $4.8M | 41 | -9% | N/A |
#4 | $8.9M | 41 | -9% | N/A |
#5 | $8M | 41 | 8% | N/A |